CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 265 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $206 | -87.8% | 12,921 | -91.1% | 0.00% | -100.0% |
| Q3 2023 | $1,692 | +103.1% | 144,699 | +133.6% | 0.00% | +100.0% |
| Q2 2023 | $833 | -70.1% | 61,955 | -63.1% | 0.00% | -75.0% |
| Q1 2023 | $2,782 | -98.0% | 167,787 | +758.3% | 0.00% | – |
| Q2 2022 | $137,000 | -94.8% | 19,548 | -93.8% | 0.00% | -100.0% |
| Q1 2022 | $2,613,000 | +119.2% | 315,151 | +79.0% | 0.00% | +200.0% |
| Q4 2021 | $1,192,000 | +631.3% | 176,049 | +471.6% | 0.00% | – |
| Q3 2021 | $163,000 | -83.5% | 30,800 | -89.6% | 0.00% | -100.0% |
| Q4 2020 | $986,000 | +236.5% | 295,292 | +365.8% | 0.00% | 0.0% |
| Q2 2020 | $293,000 | -89.3% | 63,400 | -91.3% | 0.00% | -83.3% |
| Q4 2019 | $2,742,000 | – | 731,259 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 17,875,655 | $94,920,000 | 9.39% |
| TANAKA CAPITAL MANAGEMENT INC | 283,334 | $1,505,000 | 4.86% |
| GABLES CAPITAL MANAGEMENT INC. | 490,564 | $2,606,000 | 1.84% |
| MANGROVE PARTNERS IM, LLC | 2,508,838 | $13,322,000 | 1.61% |
| Broadfin Capital, LLC | 880,303 | $4,674,000 | 0.86% |
| Atom Investors LP | 1,012,355 | $5,376,000 | 0.37% |
| Capital Impact Advisors, LLC | 179,868 | $948,000 | 0.36% |
| KNOTT DAVID M | 151,415 | $804,000 | 0.34% |
| EMERALD ADVISERS, LLC | 1,175,958 | $6,244,000 | 0.29% |
| CADENCE CAPITAL MANAGEMENT LLC | 371,075 | $1,970,000 | 0.28% |